Document Detail


Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate.
MedLine Citation:
PMID:  16084097     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have synthesized a conjugate of cis-4,7,10,13,16,19-docosahexenoic acid (DHA) and 10-hydroxycamptothecin (HCPT), DHA-HCPT. The antitumor activity of DHA-HCPT was evaluated in vitro against L1210 leukemia cells and in experimental animal tumor models including L1210 leukemia, Lewis lung carcinoma, and colon 38 adenocarcinoma. DHA-HCPT showed a greatly improved antitumor efficacy compared to HCPT.
Authors:
Yuqiang Wang; Lianfa Li; Wei Jiang; James W Larrick
Related Documents :
3556847 - A model for evaluating the stressed patient in the family practice setting.
9751847 - Evaluation of igg rast feia for the assay of venom-specific igg antibodies during venom...
9383837 - Alternative medical treatment for endometriosis.
10733187 - Electrode to modiolus proximity: a fluoroscopic and histologic analysis.
15326887 - Clinical description and review of migraine aura without headache.
2868817 - Treatment of urticaria.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Bioorganic & medicinal chemistry     Volume:  13     ISSN:  0968-0896     ISO Abbreviation:  Bioorg. Med. Chem.     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-08-22     Completed Date:  2005-12-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9413298     Medline TA:  Bioorg Med Chem     Country:  England    
Other Details:
Languages:  eng     Pagination:  5592-9     Citation Subset:  IM    
Affiliation:
Institute of New Drug Research, Jinan University College of Pharmacy, Guangzhou 510632, China. yuqiangwang2001@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy*
Animals
Antineoplastic Agents* / chemical synthesis,  pharmacology
Camptothecin / analogs & derivatives*,  chemical synthesis,  pharmacology
Carcinoma, Lewis Lung / drug therapy*
Cell Line, Tumor
Cell Proliferation / drug effects
Colonic Neoplasms / drug therapy*
Disease Models, Animal
Docosahexaenoic Acids* / chemical synthesis,  pharmacology
Drug Design
Drug Screening Assays, Antitumor
Humans
Leukemia L1210 / drug therapy*
Mice
Molecular Conformation
Stereoisomerism
Structure-Activity Relationship
Grant Support
ID/Acronym/Agency:
CA 82949/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/DHA-HCPT conjugate; 25167-62-8/Docosahexaenoic Acids; 67656-30-8/10-hydroxycamptothecin; 7689-03-4/Camptothecin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CREB: the unindicted cancer co-conspirator.
Next Document:  Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B.